Senores Pharmaceuticals has informed that it enclosed a certificate, pursuant to regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, received from MUFG Intime India (formerly known as Link Intime India), Registrar and Share Transfer Agent of the Company, for the quarter ended March 31, 2025.
The above information is a part of company’s filings submitted to BSE.